Byfavo™ (remimazolam) – New drug approval
July 2, 2020 - Cosmo Pharmaceuticals and Acacia Pharma announced the FDA approval of Byfavo (remimazolam), for the induction and maintenance of procedural sedation in adults undergoing procedures lasting 30 minutes or less.
Download PDF
